Cocrystal Pharma (NASDAQ:COCP – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.55) per share for the quarter.
Cocrystal Pharma Price Performance
Shares of NASDAQ:COCP opened at $1.48 on Wednesday. The business’s 50-day moving average is $1.84 and its 200 day moving average is $1.94. Cocrystal Pharma has a 1 year low of $1.35 and a 1 year high of $3.26. The firm has a market capitalization of $15.06 million, a P/E ratio of -0.80 and a beta of 2.35.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Cocrystal Pharma in a research report on Wednesday, January 22nd.
About Cocrystal Pharma
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- Best Stocks Under $10.00
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What Investors Need to Know to Beat the Market
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What is a Stock Market Index and How Do You Use Them?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
